FMR1NB Involved in Glioma Tumorigenesis Is a Promising Target for Prognosis and Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FMR1NB Involved in Glioma Tumorigenesis Is a Promising Target for Prognosis and Therapy

Published:2022-07-11 Issue:4 Volume:42 Page:803-816
ISSN:2096-5230
Container-title:Current Medical Science
language:en
Short-container-title:CURR MED SCI

Author:

Bi Shui-qing,Peng Ya,Wei Zong-dang,Yao Sheng-zhong,Luo Bin,Ge Ying-ying,Xie Xiao-xun,Nong Wei-xia,Liu Chang,Xiao Shao-wen,Zhang Qing-mei

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s11596-022-2586-4.pdf

Reference48 articles.

1. Ostrom QT, Gittleman H, Liao P, et al. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro Oncology, 2017,19(suppl_5):v1–v88

2. Yang P, Wang Y, Peng X, et al. Management and survival rates in patients with glioma in China (2004–2010): a retrospective study from a single-institution. J Neurooncol, 2013,113(2):259–266

3. Wang HW, Xu ZK, Song Y, et al. Correlations of MGMT genetic polymorphisms with temozolomide resistance and prognosis of patients with malignant gliomas: a population-based study in China. Cancer Gene Ther, 2017,24(5):215–220

4. Li K, Lu D, Guo Y, et al. Trends and patterns of incidence of diffuse glioma in adults in the United States, 1973–2014. Cancer Med, 2018,7(10):5281–5290

5. Ehtesham M, Black KL, Yu JS. Recent Progress in Immunotherapy for Malignant Glioma: Treatment Strategies and Results from Clinical Trials. Cancer Control, 2004,11(3):192–207

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer;Molecular Therapy: Oncology;2024-03

2. Cancer Stem Cell Biomarkers in the Nervous System;Frontiers in Bioscience-Landmark;2023-12-29

3. EDEM2 is a diagnostic and prognostic biomarker and associated with immune infiltration in glioma: A comprehensive analysis;Frontiers in Oncology;2023-01-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3